MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Huntington disease phenocopies or misdiagnosis: A black South African cohort

F.K. Baine, A. Krause (Johannesburg, South Africa)

Meeting: 2016 International Congress

Abstract Number: 1099

Keywords: Ataxia: Genetics, Chorea (also see specific diagnoses, etc): Genetics, Huntingtons disease, Spinocerebellar ataxias(SCA)

Session Information

Date: Wednesday, June 22, 2016

Session Title: Huntington's disease

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To investigate the occurrence of phenocopy mutations in a cohort of black South African individuals referred to the National Health Laboratory Service (NHLS) for Huntington disease confirmatory molecular testing.

Background: Huntington disease (HD) is a disabling neurodegenerative disorder caused by an unstable expanded trinucleotide (CAG) repeat in the huntingtin (HTT) gene. The condition characteristically presents with a triad of symptoms: behavioural problems, movement disorder and cognitive decline. Internationally, between 1 and 7% of individuals clinically diagnosed with HD do not carry the mutation and are said to have an HD phenocopy (Wild et al. 2008); a term used to describe any syndrome that manifests HD-like symptoms in the absence of an HTT expansion. In South Africa, direct mutation testing for HD is performed in the public sector by the NHLS. A significant proportion (30-40%) of patients referred for molecular diagnostic confirmation does not carry an expansion in the HTT gene and may therefore have a phenocopy. Up to one third of these patients have been found to carry a repeat expansion in the junctophilin-3 (JPH3) gene underlying Huntington disease-like 2 (HDL2), an African specific phenocopy (Krause et al 2015). As a result, HDL2 has been incorporated into routine diagnostic testing for HD referrals. However, many patients test negative for both mutations and therefore have no molecular diagnosis.

Methods: Record review identified 105 black South Africans referred to the NHLS who had previously tested negative for both the HTT and JPH3 expansions. Molecular laboratory testing protocols were undertaken for selected HD phenocopies including Spinocerebellar ataxia (SCA) subtypes: 1, 2, 7, 17; Dentatorubral-palidolluysian atrophy (DRPLA) and the recently identified C9orf72 hexanucleotide expansions.

Results: A systematic screen for each of the above-named disorders was undertaken. SCA2 has been confirmed in one individual and results are anticipated for the DRPLA and C9orf72 mutation screen. No mutations have been identified for SCA 1, 7 and 17.

Conclusions: This is the first systematic investigation of a South African cohort for the presence of mutations underlying HD phenocopies. Initial results suggest that misdiagnosis may be commonly encountered in the South African setting.

To cite this abstract in AMA style:

F.K. Baine, A. Krause. Huntington disease phenocopies or misdiagnosis: A black South African cohort [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/huntington-disease-phenocopies-or-misdiagnosis-a-black-south-african-cohort/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/huntington-disease-phenocopies-or-misdiagnosis-a-black-south-african-cohort/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley